Kent E. Ausburn

Kent E. Ausburn is a declared insider of Kaneh Bosm BioTechnology Inc., with filings sourced from SEDI. In total, 3 filings cover trades dated from 17 May 2017 to 2 November 2017.

On the market, this insider has only sold: 1 sale, €2,445 in total. Since January 2018: no purchases and 1 sale on the market.

The newest entry dates from 1 March 2018: an open-market sale of €2,445, in Kaneh Bosm BioTechnology Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEDI disclosures alone and does not predict where the share price will go.